These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8769221

  • 21. Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients.
    Diliz HS, Olivera MA, Kershenobich D, Mercado MA, Orozco H.
    Transplant Proc; 1996 Dec; 28(6):3348-50. PubMed ID: 8962302
    [No Abstract] [Full Text] [Related]

  • 22. Microemulsion cyclosporine (Neoral) immunosuppression for orthotopic liver transplantation in children reduces hospital stay.
    Arumugam R, Soriano HE, Scheimann AO, Reid BS, Gopalakrishna GS, Barakat O, Ozaki CF, Wood RP.
    Transplant Proc; 1998 Aug; 30(5):1848-9. PubMed ID: 9723304
    [No Abstract] [Full Text] [Related]

  • 23. Frequency of switch from cyclosporine to FK 506 before and after Neoral use in pediatric liver transplantation.
    Gridelli B, Colledan M, Lucianetti A, Ulla L, Riva S, Segalin A, Fassati LR, Torre G.
    Transplant Proc; 1998 Aug; 30(5):1861-2. PubMed ID: 9723311
    [No Abstract] [Full Text] [Related]

  • 24. Use of Neoral in pediatric renal transplantation.
    Ettenger RE, Smith HT, Kaiser B, Cooney GF, Summerauer J, Alexander S, Moulton LT, Choc MG, Wong RL.
    Transplant Proc; 1996 Aug; 28(4):2257-8. PubMed ID: 8769217
    [No Abstract] [Full Text] [Related]

  • 25. Neoral-based immunosuppression in living-related donor liver transplantation.
    Liu PP, Chen CL, Chen YS, Wang CC, Chiang YC, Goto S, Cheng YF, Huang TL, Eng HL, Cheung HK, Jawan B.
    Transplant Proc; 1998 Nov; 30(7):3550-1. PubMed ID: 9838554
    [No Abstract] [Full Text] [Related]

  • 26. Sandimmun neoral improves the bioavailability of cyclosporin A and decreases inter-individual variations in patients affected with cystic fibrosis.
    Girault D, Haloun A, Viard L, Bellon G, Gottrand F, Guillemain R, Lenoir G, Ladurie FL, Plouvier E, Storni V.
    Transplant Proc; 1995 Aug; 27(4):2488-90. PubMed ID: 7652899
    [No Abstract] [Full Text] [Related]

  • 27. Neoral as the initial immunosuppressant in liver transplantation; conversion from Sandimmune to Neoral in stable patients.
    Kizilisik AT, al-Sebayel M, Ramirez CB.
    Transplant Proc; 1998 Nov; 30(7):3537-8. PubMed ID: 9838549
    [No Abstract] [Full Text] [Related]

  • 28. Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients.
    Takatsuki M, Chen CL, Chen YS, Wang CC, Lin CC, Yang CH, Yong CC, Liu YW.
    Clin Transplant; 2004 Dec; 18(6):694-9. PubMed ID: 15516246
    [Abstract] [Full Text] [Related]

  • 29. Cyclosporine-based immunotherapy for pediatric liver transplantation in Hong Kong.
    Chan KL, Saing H, Fan ST, Wei WI, Ng IO, Tsoi NS.
    Transplant Proc; 1996 Jun; 28(3):1302-3. PubMed ID: 8658669
    [No Abstract] [Full Text] [Related]

  • 30. Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.
    Dibo-Cohen JM, Conort O, Conti F, Bernard D, Hazebroucq G, Calmus Y.
    Transplant Proc; 1998 Aug; 30(5):1857. PubMed ID: 9723309
    [No Abstract] [Full Text] [Related]

  • 31. NOF-11: a one-year randomized double-blind comparison of Neoral versus Sandimmune in pediatric liver transplantation.
    Alvarez F, Atkison P, Grant D, Jones A, Kim P, Kneteman N, Laurin L, Martin S, Paradis K, Shapiro J, Smith L, Superina R, Tan A.
    Transplant Proc; 1998 Aug; 30(5):1961. PubMed ID: 9723352
    [No Abstract] [Full Text] [Related]

  • 32. Settling the question: Sandimmune or Neoral?
    Hull AR.
    Nephrol News Issues; 1996 May; 10(5):9. PubMed ID: 8715799
    [No Abstract] [Full Text] [Related]

  • 33. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
    Reggiani P, Rossi G, Latham L, Caccamo L, Gatti S, Maggi U, Melada E, Paone G, Doglia M, Vannelli A, Fassati LR.
    Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
    [No Abstract] [Full Text] [Related]

  • 34. Immunosuppressive therapy with microemulsion cyclosporine A shortens the hospitalization of pediatric liver transplant recipients.
    Arumugam R, Soriano HE, Scheimann AO, Reid BS, Gopalakrishna GS, Barakat O, Ozaki CF, Wood PR.
    Clin Transplant; 1998 Dec; 12(6):588-92. PubMed ID: 9850457
    [Abstract] [Full Text] [Related]

  • 35. Mass conversion from Sandimmun to Sandimmun Neoral: 1 1/2-year experience.
    Huraib S, al Khudair W, Selim H, Iqbal A, Quadri K, Abu Romeh S, Chaballout A.
    Transplant Proc; 1997 Nov; 29(7):2980-2. PubMed ID: 9365637
    [No Abstract] [Full Text] [Related]

  • 36. Sandimmun Neoral: Taiwanese experience in renal transplant patients with special reference to patients with existing liver disease.
    Lee PH, Hu RH, Tsai KS, Chern HD, Gau YS, Chen RR.
    Transplant Proc; 1996 Jun; 28(3):1327. PubMed ID: 8658679
    [No Abstract] [Full Text] [Related]

  • 37. Changing stable heart transplant recipients from Sandimmune to Neoral.
    Dalrymple-Hay M, Meara M, Reynolds L, Backhouse L, Wright D, Holt D, Johnston A, Madden B, Murday A.
    Transplant Proc; 1996 Aug; 28(4):2285-6. PubMed ID: 8769227
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral.
    Baruch Y, Weitzman E, Markiewicz W, Eisenman A, Eid A, Enat R.
    Transplant Proc; 1996 Aug; 28(4):2250-1. PubMed ID: 8769215
    [No Abstract] [Full Text] [Related]

  • 40. Relative bioavailability of Sandimmune and Sandimmune Neoral in pediatric liver recipients.
    Superina RA, Strong DK, Acal LA, DeLuca E.
    Transplant Proc; 1994 Oct; 26(5):2979-80. PubMed ID: 7940940
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.